chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had both shots and i still got the shingles /suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, had 2 shots and still got shingles. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation for shingles were not provided.
On May 8th, 2021 my mother went to get her Covid vaccine and today they called saying that she was given a bad vaccine. Today she said that the store kept calling and she was unsure why until she picked up and learned that she shot was bad. The pharmacist told her that the vaccine given to her was not stored at the proper temperature at the time of getting the shot. She told my mom that this location will no longer be giving the vaccine and that they could schedule her an appointment at a different place. They told her they were sorry for the inconvenience and said that they would mail her a $50 gift card. I don't understand how a $50 gift card can equal the value of a human life. I feel that if you are a licensed pharmacist then you should know how to store medicine and I feel that this is gross negligence. How many more people have received a bad vaccine from this place?  Now we have to worry about if her health is going to get worse due to this. What upsets me more is that it took them 4 to 5 days for them to even realize they had it at the wrong temperature.
The day after injection very achy from head to toe, joint and muscles, it feels like he was cutting wood for a whole day. It feels like he has the flu real bad, but his blood sugar has been stable so far his type II diabetes isn't bothering him.
Swelling, mild erythema of injection site, developing 24-48 hours after injection.
Child's left arm where the vaccine had been administered the day before was swollen, reddened, seeping clear fluid, mildly tender. The mother took the child to a pediatrician this morning who diagnosed it as cellulitis and gave the child antibiotics. The mother came back to our clinic afterward to report the incident.
Hives all over the body; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the second dose of BNT162B2 (PFIZER COVID-19 VACCINE, lot number: unknown), in left arm on 13May2021 10:00 at single dose for covid-19 immunisation. Medical history included known sulfa and shellfish allergies. The patient was not pregnant at time of vaccination. The patient was not diagnosed with covid-19 prior to vaccination. The patient didn't receive any other vaccines within 4 weeks prior to vaccination. The patient previously received the first dose of BNT162B2 (lot number: unknown), on an unspecified date at single dose for covid-19 immunisation. The patient experienced hives all over the body on 14May2021 16:00. The patient had not been tested for covid-19 since the vaccination. Therapeutic measures were taken as a result of hives all over the body and included treatment with oral steroids. The outcome of the event hives all over the body was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Might be hives; Rough; Redness; Dizziness; Swollen neck; swollen face; Reddish rash all over her body warm and slightly raised,upperbody rash; Fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Might be hives), DRY SKIN (Rough), ERYTHEMA (Redness), DIZZINESS (Dizziness) and SWELLING (Swollen neck) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol. Concomitant products included ATORVASTATIN for Cholesterol, ASPIRIN [ACETYLSALICYLIC ACID], VITAMIN D NOS, LUTEIN;VITAMINS NOS and FISH OIL for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced URTICARIA (Might be hives), DRY SKIN (Rough), ERYTHEMA (Redness), DIZZINESS (Dizziness), SWELLING (Swollen neck), SWELLING FACE (swollen face), RASH (Reddish rash all over her body warm and slightly raised,upperbody rash), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. On 27-Apr-2021, URTICARIA (Might be hives), ERYTHEMA (Redness), DIZZINESS (Dizziness), SWELLING (Swollen neck), SWELLING FACE (swollen face), RASH (Reddish rash all over her body warm and slightly raised,upperbody rash), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, DRY SKIN (Rough) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient stated that her skin felt like sandpaper when the rash subsided, which was rough. She stated that one and a half month later of receiving the second moderna vaccine, her skin felt normal and heat from hot shower seemed to make her skin feel rough.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Updated patient demographics, event term rash with upper body rash. event outcome for all events to recovered/resolved.Added new events (dry skin, fever, chills, dizziness, swollen neck and face), concomitant medication atorvastatin.
It started with an eruption of reddish skin and after a few days it has warts.
9 months post-vaccination with MMR and VAR vaccines, patient developed vesicular rash limited in distribution to L4 dermatome on right side only. Clinically consistent with zoster. Spread in this distribution over 5 days, with initial lesions scabbed over at day 5. Patient was otherwise well at time of visit for rash. Interestingly, the rash did not seem to bother patient, though mom kept her in pants to keep her from being able to touch the rash. We do have photo documentation of rash, if would be helpful. No samples taken or labs done at this time, will be doing CBC in follow-up with delayed due to pandemic.
c'pox dx 10-17-07-calamine lotion Benadryl out of school
Got vaccination at 11am. At 7pm felt general feeling of malaise. Went to bed at 9:30 but had trouble getting to sleep. Woke up at 5am with body aches and headache. Sat on the toilet but felt dizzy, had ringing in my ears, and felt woosy. Laid  back on bed and raised feet above my head. Took my temperature, it was 99.3F, which is a little high for me.  Ringing stopped after I laid down.
-Erythematous rash @ injection site that's warm 9cm mv x 9"2cm mv  -strange dreams -very bad headache 8/10
Systemic: Chills-Medium, Systemic: Hypertension-Mild, Systemic: Tachycardia-Mild, Additional Details: 10 mins after Pt received vaccine she reported she had chills and was cold. Pt was slightly hypertensive at 145/93 and HR of 116 temp 98.3. Pt did not feel light headed, had no trouble breathing and was AOx4. Medics called at Pt request and full work up done. Medics cleared EKG. Described as Pt panic attack. Last BP 122/83 HR 90 RR 18 and temp 97.8. After Pt assessment complete, Pt wanted to go home and call if she noticed any further symptoms. Medics walked Pt to car with no adverse reaction.
Patient was 15 years, 11 months, and 14 days at the time of vaccination. The adverse event occurred at a mass vaccination event for the Community and language was probable in the reason for this miscommunication. The dosage was administered inadvertently. Followed up with the patient's parents after becoming aware on 04/15/2021. and the mother informed us that the patient was doing well and has had no reactions to the vaccine. Patient's second dose is scheduled for her 16th birthday. Small clinic in charge of the event has implemented re-education for staff and volunteers.
Patient was tested as protocol for a program she was entering and tested positive- does not have any signs or symptoms of covid
Pt report possible reaction to Flu vaccine on 9/29/23.  Pt Received vaccine at 1000 and at 1005 started to feel right side of throat closing, face warm and red, no difficulty of breathing, took Benadryl 50mg. Had same reaction to Covid vac., no reaction to Flu vac the last 2 years . Had similar reaction to  non- preservative Flu vac. in the past. HX. of multiple allergies, Pt carries own Epi Pen.  Pt was sent and treated to ER. Pt was given Prednisone, Pepcide and Benadryl and was kept for few hours for observation. Pt was recommended to be on Pepcid for days. Pt feels alot better now but still have scratchy throat. Advised to follow up with PCP if worsening or new symptoms arise.
sore arm; a slight fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) and PYREXIA (a slight fever) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 immunisation.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm) and PYREXIA (a slight fever). At the time of the report, VACCINATION SITE PAIN (sore arm) and PYREXIA (a slight fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided   This case was linked to MOD-2021-027597 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: Event outcome updated from unknown to recovered.
Patient received Rotateq at 2 m visit, 2/13/08.  Admitted to hospital ~2 days later, found to have intussusception -> treated with colonoscopy. 5/9/08-clinic follow up visit notes received for DOS 2/20/08-DX: Intussusception. Second attempt at reduction successful.  5/14/08-records received for DOS 2/17-2/19/08-DC DX: Intussusception status post reduction barium enema. History of nonbloody nonbilious emesis times 2 and decreased energy level and poor feeding for approximately 1 day prior to admission. Presented to transferring facility ED where 3 attempts to reduce by barium enema failed. Replogle placed to suction.
VARlVAX had a temperature excursion and was administered; Additional AE's were reported; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were not provided.  On an unknown date, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot# T028306 has been verified to be a valid lot number, expiration date was reported as 20-AUG-2022; strength and route were not reported) 5 ml once for prophylaxis. The vaccine was stored under 4 Fahrenheit (F) for 24 hours. There was no previous temperature excursion. On 28-JUN-2021, the patient experienced unspecified adverse event. The outcome of the event was unknown. The causality assessment between the event and varicella virus vaccine live (oka/merck) (VARIVAX) was not reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2107USA000237:01957083 US-009507513-2107USA000111:01957080 US-009507513-2107USA000236:01957053 US-009507513-2107USA000238:01957079
pt recv vax 5MAR97 & babysitter noted pt feeling warm @ 10PM;pt was fussy & sweaty-t105 R;no sz went to ER told to give Advil & APAP alternately 9:30 t101.5 & doing better;
(11/2/07) Patient called on Friday at 1:30pm complained sorethroat and difficulty in swallowing. The immunizer recommended him to take Benadryl. We called him back on Monday (11/5/07) to follow up. Patient said he was feeling fine after 3 doses of Benadryl.
Parent requested the COVID vaccine to be given in office for the patient. The wrong presentation was given. I contacted the health department and they stated it will not be a risk to the patient. Parent will be notified by me via phone call.
body aches, chiils, fatigue, cough, congestion Narrative:  On day 3 experienced body aches, chills, fatigue, cough, sinus congestion and feel like she was hit by a bus
Dizziness lasting more than 3 weeks and lasting hours to days, heart palpitations, numbness in the arms and finger tips, sweating and shaking while eating, high blood pressure 150 sys that's not normal for me, dizziness while walking short distances like 20 ft to my kitchen, at times exsesive hunger, blurry vision.
I21.4 ACUTE NON ST ELEVATION MI 12/30/2021 ANEMIA DUE TO CKD I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 1/6/2022 ANEMIA DUE TO CKD I95.9 HYPOTENSION 12/29/2021 ANEMIA DUE TO CKD I21.4 ACUTE NON ST ELEVATION MI 12/30/2021 ESRD (END STAGE RENAL DISEASE) I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 1/6/2022 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 12/29/2021 ESRD (END STAGE RENAL DISEASE) I21.4 ACUTE NON ST ELEVATION MI 12/30/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 1/6/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA I95.9 HYPOTENSION 12/29/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I21.4 ACUTE NON ST ELEVATION MI 12/30/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 1/6/2022 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION I95.9 HYPOTENSION 12/29/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION I21.4 ACUTE NON ST ELEVATION MI 12/30/2021 ACUTE NON ST ELEVATION MI I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 1/6/2022 ACUTE NON ST ELEVATION MI I95.9 HYPOTENSION 12/29/2021 ACUTE NON ST ELEVATION MI
Patient had severe pain in left arm that would throb throughout the day and she had difficulty raising her arm over her head. She went to her PCP to assess and they couldn't find anything wrong in the area. Pain resolved over time (gone after 7 days) and is no longer present.
Pt had low grade fever & some fussiness for 48 hrs p/immun; A little more than 48 hrs p/immun pt devel trembling tonic/clonic motor activity w/change in mental status assoc w/high fever (? to approx 106); Taken to ER, fontanelle noted full;
Twenty hrs after shot began to have fatigue, this increased. By 24 hr after shot body aches began. This continued worsening so had very little control of legs and body. At about 30 hrs after shot had to call 911. BP & pulse not extreme but much higher than normal. I, his wife, had to help hold him in upright position so EMS tech could get his vitals. They helped get him in bed (refused ride to hospital). Approx 36 hrs after shot began to see some control returning. Approx 40-42 hrs after shot most side effects gone, only a little tiredness remained. By day 3 all better.
He has hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (He has hives) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced URTICARIA (He has hives). At the time of the report, URTICARIA (He has hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs and treatment information was reported.   This case was linked to MOD21-092206 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-092206:
Within hours, I noticed speech impairment. I was having trouble recalling words.  I was also slurry my words (not as pronounced as in the 1st dose).  I felt like my brain felt "concussed".  It feels like brain fog and it  takes extra time to get words out.  My short term memory has been affected and I am having difficulty focusing.  I am still suffering from brain fog and my short term memory is not as sharp anymore.
AT OFFSITE MASS VACCINATION CLINIC, PATIENT WAS GIVEN PFIZER COVID VACCINE WHEN HE WAS NOT YET 16 YEARS OLD (JUST 4 DAYS SHY OF BIRTHDAY). DISCOVERED THE WEEK AFTER WHEN PHARMACY WAS PROCESSING THE CLINIC PAPERWORK.
vial that was left at room temperature since yesterday; no adverse event; vaccine administered to patient more than 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered to patient more than 12 hours post puncture), PRODUCT STORAGE ERROR (vial that was left at room temperature since yesterday) and NO ADVERSE EVENT (no adverse event) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011B22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 24-Aug-2022 at 2:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Aug-2022 at 2:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered to patient more than 12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial that was left at room temperature since yesterday) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine administered to patient more than 12 hours post puncture), PRODUCT STORAGE ERROR (vial that was left at room temperature since yesterday) and NO ADVERSE EVENT (no adverse event) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (vaccine administered to patient more than 12 hours post puncture) and PRODUCT STORAGE ERROR (vial that was left at room temperature since yesterday).    No concomitant drug was reported. It was stated that a patient received 2nd booster dose of the vaccine from a vial that was left at room temperature since 23AUG2022. The vial was first punctured on 23AUG2022 at 2:14 PM and the dose was administered on 24AUG2022 at 2:00 PM (Lot 011B22A). The patient had not reported any adverse reactions at this time. No Treatment medications were reported.
Paralysis of right eye; Double vision; cataract in right eye; Walking difficulty; eye pain; This spontaneous case was reported by a physician and describes the occurrence of OPHTHALMOPLEGIA (Paralysis of right eye), DIPLOPIA (Double vision) and CATARACT (cataract in right eye) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Glaucoma and Cataract (left) in 2019. Concurrent medical conditions included Cataract (right). Concomitant products included LOSARTAN, METOPROLOL, AMLODIPINE, HYDROCHLOROTHIAZIDE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), MULTIVITAMIN [VITAMINS NOS], VITAMIN D NOS and ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced EYE PAIN (eye pain). On 09-Mar-2021, the patient experienced OPHTHALMOPLEGIA (Paralysis of right eye) (seriousness criteria hospitalization, disability and medically significant) and DIPLOPIA (Double vision) (seriousness criterion hospitalization). On an unknown date, the patient experienced CATARACT (cataract in right eye) (seriousness criterion medically significant) and GAIT DISTURBANCE (Walking difficulty). The patient was hospitalized from 09-Mar-2021 to 13-Mar-2021 due to DIPLOPIA and OPHTHALMOPLEGIA. At the time of the report, OPHTHALMOPLEGIA (Paralysis of right eye), DIPLOPIA (Double vision), CATARACT (cataract in right eye), EYE PAIN (eye pain) and GAIT DISTURBANCE (Walking difficulty) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
hospitalization 1NOV98-10NOV98 w/pneumonia;T103;
anaphylactic reaction; the patient's tongue started swelling; allergic reaction; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 2022NVX-US-000004032 (Novavax).  A female patient received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (hospitalization, medically significant), outcome "recovered"; SWOLLEN TONGUE (hospitalization), outcome "unknown", described as "the patient's tongue started swelling"; HYPERSENSITIVITY (hospitalization), outcome "unknown", described as "allergic reaction". Therapeutic measures were taken as a result of anaphylactic reaction, swollen tongue, hypersensitivity.  Clinical course: "On 28Oct2022"(as reported), it was reported that a patient started treatment on an unspecified date in Jan2021 with Pfizer BioNTech COVID-19 Vaccine at dose 1 for COVID-19 immunization. It was reported the patient experienced an anaphylactic reaction to the vaccine. The patient waited 30 minutes instead of 15 minutes. Within the waiting time, the patient's tongue started swelling. The patient went to the hospital for observation after she was given the medication for the allergic reaction, but she reported she was okay.  The information on the batch/lot number for (BNT162B2), has been requested and will be submitted if and when received.
Patient was 5 years old at the time of administration for dose 3 on 10/28/2022, patient not turning 6 until  12/7/2022. Since patient is 5 years old at time of vaccine , patient should have received Pfizer bivalent booster ( 0.2ml 10mcg) only and should not have started the Moderna series or received the Moderna monovalent vaccine dosage of 0.2ml 3mcg.